Product news from 11/18/05 News Brief

Share this article:

The FDA approved Roche and Genentech's Tarceva (erlotinib) for a new indication as a treatment for patients with advanced pancreatic cancer. Tarceva has previously been approved by the FDA as a treatment for lung cancer.

Reliant Pharmaceuticals announced the FDA has approved its Supplemental New Drug Application for a new dosing regimen and label change for the fenofibrate therapy Antara (fenofibrate capsules) 43 mg and 130 mg. The new regimen enables patients to take Antara 130 mg capsules with or without food, increasing convenience for the 15% of adults in the U.S. with elevated triglycerides.

Share this article:

Email Newsletters

More in News

Astellas, DOJ settle for $7.3M

Astellas, DOJ settle for $7.3M

Astellas has settled a False Claims case with the Department of Justice over the 2010-2013 marketing of an antifungal medication. Astellas denies the allegations.

Boehringer drug lands US, EU orphan tag

Boehringer drug lands US, EU orphan tag

The experimental Breakthrough Therapy treatment is for acute myeloid leukemia.

Omnio app moves to smartphones

Omnio app moves to smartphones

Physicians Interactive is introducing the third wave of its Omnio app, making the tablet-only tool available for iPhones and Android phones.